Lisa Bance, Kristyn Feldman and Aaron Mitchell co-wrote this blog post with Venkat Sethuraman.
Truly patient-centric clinical trials enable sponsors to more directly and methodically align the objectives of a clinical trial to the true needs of patients, and can result in more meaningful endpoints, an up-front understanding of operational issues, enhanced patient recruitment and patient retention, and better support for participating sites. But the strategies and skills necessary to design and execute successful, patient-centric clinical trials in this dynamic environment must keep pace with the changing landscape of empowered patients, drug development and healthcare.
Based on our extensive experience and original research conducted with clinical trial participants and pharmaceutical executives, we created a framework to address the evolving concept of patient-centric clinical trials. These four pillars of patient centricity adapt to different phases of development, allow organizations to apply patient-centric strategic thinking to their trials, and provide guidelines to develop processes that would lead to a successful trial design or refine their efforts to move to the next level of patient centricity.
In this article, ZS experts share:
- The four pillars of patient-centric drug development
- How life sciences companies can improve clinical trials—and the patient experience—with patient centricity
- Key principles of patient-centric strategic thinking